Dubai to host 11th GCC Regulatory Affairs Summit in June 2026

Dubai will host the 11th GCC Regulatory Affairs Summit from 22-26 June 2026, drawing more than 650 regulators, industry leaders and compliance experts to focus on pharma regulation, safety, quality and digital transformation across the GCC. The agenda includes sessions on AI, pharmacovigilance, eCTD training, supply chain resilience and regional manufacturing.

Why it matters: - The summit lands as GCC pharma regulators and companies face faster-moving rules, higher safety expectations and more pressure to modernize compliance systems. - The event is designed to shape how the region handles AI, pharmacovigilance, quality oversight and supply chain resilience. - More than 650 regulators, regulatory affairs leaders and industry decision-makers are expected to attend.

What happened: - Dubai will host the 11th GCC Regulatory Affairs Summit from 22-26 June 2026 at the Mövenpick Grand Al Bustan. - The summit runs under the theme “Shaping the Future of Regulatory Affairs: Trust, Technology & Transformation.” - The event focuses on the evolving landscape of compliance and innovation across the GCC.

The details: - The 2026 agenda covers regional regulatory authority updates, ATMPs, vaccines, biologics and biosimilars, OTC standards, pharmaceutical localization, regional manufacturing, track and trace, and supply chain resilience. - The programme also highlights AI in regulatory oversight, digital regulatory control, pharmacovigilance innovation, patient-centric safety, inspection readiness, pharmaceutical quality oversight, data integrity and AI-driven quality systems. - The summit will include three conferences: the GCC Regulatory Affairs Pharma Summit on 22-23 June, the GCC Pharmacovigilance Training on 24-25 June, and the GCC Quality Conference on 26 June. - A full day of hands-on eCTD Training is scheduled for 25 June. - eCTD Workshop Sponsor support comes from cormeo | Docuvera – EXTEDO – Rote Liste – medicines.ie. - Supporters include CEPI, Haleon, Gulf Pharmaceutical Industries (Julphar), VISIOTT | TPS, Ipsen, Schlafender Hase and EVOTEQ. - Additional sponsors include Neuraxpharm, Galderma, Biocon Limited, Acino, Pi Pharma Intelligence, LSPedia, AKT Health, CosmoTrace, Veragence Pharma Consultancy and PRA Consultancy. - The summit uses presentations, panel discussions, training workshops, case-based learning and networking opportunities. - More information and the latest agendas are available at the summit website. - The event also has a LinkedIn page at the summit’s social profile.

Between the lines: - The program signals a shift from broad regulatory discussion to practical implementation, especially around AI, digital oversight and quality systems. - Heavy sponsor participation suggests the summit is also a major industry convening point for pharma, regulatory technology and compliance companies. - The emphasis on regional manufacturing and localization points to ongoing efforts to strengthen GCC supply chains and reduce external dependence.

What’s next: - The summit will unfold over five days in late June 2026, with specialized tracks and training spread across the week. - Organizers are expected to continue publishing agenda updates ahead of the event. - The sessions are positioned to feed into broader regional discussions on regulatory modernization and pharmaceutical resilience.

The bottom line: - Dubai’s 2026 summit aims to turn regulatory change into practical action for the GCC pharma sector, with a strong focus on technology, quality and patient safety.